• 1. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
• 2. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 3. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 4. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 5. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives N-phenylureas

Recent Advances in the Study of N-(2,5-dimethylphenyl)-2-({5-(phenylcarbamoyl)amino-1,3,4-thiadiazol-2-yl}sulfanyl)acetamide (CAS: 946323-48-4)

The compound N-(2,5-dimethylphenyl)-2-({5-(phenylcarbamoyl)amino-1,3,4-thiadiazol-2-yl}sulfanyl)acetamide (CAS: 946323-48-4) has recently garnered significant attention in the field of chemical biology and medicinal chemistry due to its promising pharmacological properties. This research brief aims to provide an updated overview of the latest findings related to this compound, focusing on its synthesis, mechanism of action, and potential therapeutic applications.

Recent studies have highlighted the compound's unique structural features, which include a 1,3,4-thiadiazole core and a phenylcarbamoyl moiety. These structural elements are believed to contribute to its bioactivity, particularly in modulating key enzymatic pathways. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that 946323-48-4 exhibits potent inhibitory effects against a range of kinases, suggesting its potential as a multi-targeted therapeutic agent.

In terms of synthesis, researchers have developed optimized protocols to improve the yield and purity of 946323-48-4. A recent paper in Organic & Biomolecular Chemistry described a novel one-pot synthesis approach that reduces the number of steps and minimizes byproducts. This advancement is expected to facilitate further preclinical and clinical studies of the compound.

Pharmacological evaluations have revealed that 946323-48-4 possesses notable anti-inflammatory and anticancer properties. For instance, in vitro studies using cancer cell lines showed that the compound induces apoptosis via the mitochondrial pathway. Additionally, animal models of inflammation demonstrated significant reduction in pro-inflammatory cytokines upon treatment with 946323-48-4.

Despite these promising findings, challenges remain in the development of 946323-48-4 as a therapeutic agent. Issues such as bioavailability, metabolic stability, and potential off-target effects need to be addressed in future research. Ongoing studies are exploring structural modifications to enhance its pharmacokinetic profile while retaining its bioactivity.

In conclusion, N-(2,5-dimethylphenyl)-2-({5-(phenylcarbamoyl)amino-1,3,4-thiadiazol-2-yl}sulfanyl)acetamide (946323-48-4) represents a promising candidate for further drug development. Its multifaceted pharmacological effects and improved synthetic accessibility position it as a valuable compound for addressing unmet medical needs. Continued research is warranted to fully elucidate its therapeutic potential and overcome existing limitations.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)